Danaher Co. (NYSE:DHR) Shares Sold by Swedbank AB

Swedbank AB decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 29.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,681,814 shares of the conglomerate’s stock after selling 710,247 shares during the quarter. Swedbank AB’s holdings in Danaher were worth $386,060,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Fort Pitt Capital Group LLC lifted its position in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC acquired a new stake in Danaher in the third quarter worth $217,000. ORG Partners LLC grew its holdings in shares of Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after acquiring an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. raised its holdings in Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after acquiring an additional 2,465 shares during the period. Finally, Stifel Financial Corp raised its position in Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 7.5 %

Danaher stock traded down $18.63 during midday trading on Wednesday, hitting $229.21. 2,731,082 shares of the company were exchanged, compared to its average volume of 2,931,083. Danaher Co. has a fifty-two week low of $225.42 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company has a market cap of $165.55 billion, a PE ratio of 43.60, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The company’s fifty day moving average price is $236.09 and its 200-day moving average price is $253.66.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same period last year, the business earned $2.09 earnings per share. On average, research analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.47%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is 20.61%.

Analyst Ratings Changes

A number of brokerages have weighed in on DHR. Stephens reiterated an “overweight” rating and set a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Royal Bank of Canada decreased their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. TD Cowen upped their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Evercore ISI boosted their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Finally, Scotiabank assumed coverage on shares of Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. Six analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $285.81.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.